|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Russo E, Taddei A, Ringressi MN, Ricci F
and Amedei A: The interplay between the microbiome and the adaptive
immune response in cancer development. Therap Adv Gastroenterol.
9:594–605. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Flemer B, Lynch DB, Brown JM, Jeffery IB,
Ryan FJ, Claesson MJ, O'Riordain M, Shanahan F and O'Toole PW:
Tumour-associated and non-tumour-associated microbiota in
colorectal cancer. Gut. 66:633–643. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakatsu G, Li X, Zhou H, Sheng J, Wong SH,
Wu WK, Ng SC, Tsoi H, Dong Y, Zhang N, et al: Gut mucosal
microbiome across stages of colorectal carcinogenesis. Nat Commun.
6:8727–8736. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bufill JA: Colorectal cancer: Evidence for
distinct genetic categories based on proximal or distal tumor
location. Ann Intern Med. 113:779–788. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tamas K, Walenkamp AM, de Vries EG, van
Vugt MA, Beets-Tan RG, van Etten B, de Groot DJ and Hospers GA:
Rectal and colon cancer: Not just a different anatomic site. Cancer
Treat Rev. 41:671–679. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Missiaglia E, Jacobs B, D'Ario G, Di Narzo
AF, Soneson C, Budinska E, Popovici V, Vecchione L, Gerster S, Yan
P, et al: Distal and proximal colon cancers differ in terms of
molecular, pathological, and clinical features. Ann Oncol.
25:1995–2001. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shan L, Konstantinov SR, Smits R and
Peppelenbosch MP: Bacterial biofilms in colorectal cancer
initiation and progression. Trends Mol Med. 23:18–30. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gao Z, Guo B, Gao R, Zhu Q and Qin H:
Microbiota disbiosis is associated with colorectal cancer. Front
Microbiol. 6:202015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang T, Cai G, Qiu Y, Fei N, Zhang M, Pang
X, Jia W, Cai S and Zhao L: Structural segregation of gut
microbiota between colorectal cancer patients and healthy
volunteers. ISME J. 6:320–329. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Flemer B, Herlihy M, O'Riordain M,
Shanahan F and O'Toole PW: Tumour-associated and
non-tumour-associated microbiota: Addendum. Gut Microbes. 8:1–5.
2018. View Article : Google Scholar
|
|
14
|
Sabino J, Vieira-Silva S, Machiels K,
Joossens M, Falony G, Ballet V, Ferrante M, Van Assche G, Van der
Merwe S, Vermeire S and Raes J: Primary sclerosing cholangitis is
characterised by intestinal dysbiosis independent from IBD. Gut.
65:1681–1689. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu N, Yang X, Zhang R, Li J, Xiao X, Hu Y,
Chen Y, Yang F, Lu N, Wang Z, et al: Dysbiosis signature of fecal
microbiota in colorectal cancer patients. Microb Ecol. 66:462–470.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Russo E, Bacci G, Chiellini C, Fagorzi C,
Niccolai E, Taddei A, Ricci F, Ringressi MN, Borrelli R, Melli F,
et al: Preliminary comparison of oral and intestinal human
microbiota in patients with colorectal cancer: A pilot study. Front
Microbiol. 8:2699–2712. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao R, Kong C, Huang L, Li H, Qu X, Liu Z,
Lan P, Wang J and Qin H: Mucosa-associated microbiota signature in
colorectal cancer. Eur J Clin Microbiol Infect Dis. 36:2073–2083.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hamady M, Walker JJ, Harris JK, Gold NJ
and Knight R: Error-correcting barcoded primers allow hundreds of
samples to be pyrosequenced in multiplex. Nat Methods. 5:235–237.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Edgar RC: UPARSE: Highly accurate OTU
sequences from microbial amplicon reads. Nat Methods. 10:996–998.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lozupone C, Lladser ME, Dan K, Stombaugh J
and Knight R: UniFrac: An effective distance metric for microbial
community comparison. Isme J. 5:169–172. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rodriguez-Castaño GP, Caro-Quintero A,
Reyes A and Lizcano F: Advances in gut microbiome research, opening
new strategies to cope with a western lifestyle. Front Genet.
7:2242017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
García-Castillo V, Sanhueza E, Mcnerney E,
Onate SA and García A: Microbiota dysbiosis: A new piece in the
understanding of carcinogenesis puzzle. J Med Microbiol.
65:1347–1362. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rajagopala SV, Vashee S, Oldfield LM,
Suzuki Y, Venter JC, Telenti A and Nelson KE: The human microbiome
and cancer. Cancer Prev Res (Phila). 10:226–234. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei Z, Cao S, Liu S, Yao Z, Sun T, Li Y,
Li J, Zhang D and Zhou Y: Could gut microbiota serve as prognostic
biomarker associated with colorectal cancer patients' survival? A
pilot study on relevant mechanism. Oncotarget. 7:46158–46172. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Caporaso JG, Lauber CL, Walters WA,
Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N and Knight R:
Global patterns of 16S rRNA diversity at a depth of millions of
sequences per sample. Proc Natl Acad Sci USA. 108:4516–4522. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen W, Liu F, Ling Z, Tong X and Xiang C:
Human intestinal lumen and mucosa-associated microbiota in patients
with colorectal cancer. PLoS One. 7:e397432012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu J, Feng Q, Wong SH, Zhang D, Liang QY,
Qin Y, Tang L, Zhao H, Stenvang J, Li Y, et al: Metagenomic
analysis of faecal microbiome as a tool towards targeted
non-invasive biomarkers for colorectal cancer. Gut. 66:70–78. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsoi H, Chu ESH, Zhang X, Sheng J, Nakatsu
G, Ng SC, Chan AWH, Chan FKL, Sung JJY and Yu J: Peptostreptococcus
anaerobius induces intracellular cholesterol biosynthesis in colon
cells to induce proliferation and causes dysplasia in mice.
Gastroenterology. 152:1419–1433. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Karlsson FH, Fåk F, Nookaew I, Tremaroli
V, Fagerberg B, Petranovic D, Bäckhed F and Nielsen J: Symptomatic
atherosclerosis is associated with an altered gut metagenome. Nat
Commun. 3:12452012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen L, Wang W, Zhou R, Ng SC, Li J, Huang
M, Zhou F, Wang X, Shen B, A Kamm M, et al: Characteristics of
fecal and mucosa-associated microbiota in Chinese patients with
inflammatory bowel disease. Medicine (Baltimore). 93:e512014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Purcell RV, Visnovska M, Biggs PJ,
Schmeier S and Frizelle FA: Distinct gut microbiome patterns
associate with consensus molecular subtypes of colorectal cancer.
Sci Rep. 7:115902017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Feng Q, Liang S, Jia H, Stadlmayr A, Tang
L, Lan Z, Zhang D, Xia H, Xu X, Jie Z, et al: Gut microbiome
development along the colorectal adenoma-carcinoma sequence. Nat
Commun. 6:65282015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun T, Liu S, Zhou Y, Yao Z, Zhang D, Cao
S, Wei Z, Tan B, Li Y, Lian Z and Wang S: Evolutionary biologic
changes of gut microbiota in an ‘adenoma-carcinoma sequence’ mouse
colorectal cancer model induced by 1,2-Dimethylhydrazine.
Oncotarget. 8:444–457. 2017.PubMed/NCBI
|
|
34
|
Kasai C, Sugimoto K, Moritani I, Tanaka J,
Oya Y, Inoue H, Tameda M, Shiraki K, Ito M, Takei Y, et al:
Comparison of human gut microbiota in control subjects and patients
with colorectal carcinoma in adenoma: Terminal restriction fragment
length polymorphism and next-generation sequencing analyses. Oncol
Rep. 35:325–333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Han YW: Fusobacterium nucleatum: A
commensal-turned pathogen. Curr Opin Microbiol. 23:141–147. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Brennan CA and Garrett WS: Gut microbiota,
inflammation, and colorectal cancer. Annu Rev Microbiol.
70:395–411. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kostic AD, Gevers D, Pedamallu CS, Michaud
M, Duke F, Earl AM, Ojesina AI, Jung J, Bass AJ, Tabernero J, et
al: Genomic analysis identifies association of Fusobacterium with
colorectal carcinoma. Genome Res. 22:292–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yan X, Liu L, Li H, Qin H and Sun Z:
Clinical significance of Fusobacterium nucleatum,
epithelial-mesenchymal transition, and cancer stem cell markers in
stage III/IV colorectal cancer patients. Onco Targets Ther.
10:5031–5046. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sheng QS, He KG, Li JJ, Zhong ZF, Wang FX,
Pan LL and Lin JJ: Comparison of gut microbiome in colorectal
cancer in paired tumor and adjacent normal tissues. OncoTargets and
Therapy. 2019.(In Press).
|
|
40
|
Schloissnig S, Arumugam M, Sunagawa S,
Mitreva M, Tap J, Zhu A, Waller A, Mende DR, Kultima JR, Martin J,
et al: Genomic variation landscape of the human gut microbiome.
Nature. 493:45–50. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zeller G, Tap J, Voigt AY, Sunagawa S,
Kultima JR, Costea PI, Amiot A, Böhm J, Brunetti F, Habermann N, et
al: Potential of fecal microbiota for early-stage detection of
colorectal cancer. Mol Syst Biol. 10:7662014. View Article : Google Scholar : PubMed/NCBI
|
